InsiderClue
Insiders · Profile

MILLIGAN JOHN F

Director at 4D Molecular Therapeutics · President and CEO at Gilead Sciences. Filing since 30 Oct 2006. CIK 0001191589

FDMT 4D Molecular Therapeutics, Inc. Director · 1 trade GILD Gilead Sciences President and CEO · 42 trades
Company
Date
Role
Action
Shares
Amount
Of holding
FDMT 4D Molecular Therapeutics, Inc.
15 Dec 2020
Director
Bought
100,000
$2.30M
opened
GILD Gilead Sciences
13 Nov 2017
President and CEO
Sold, plan not stated
220,000
$16.03M
15.9%
GILD Gilead Sciences
6 Sep 2016
President and CEO
Sold, plan not stated
70,000
$5.44M
6.2%
GILD Gilead Sciences
1 Aug 2016
President and CEO
Sold, plan not stated
70,000
$4.97M
6.2%
GILD Gilead Sciences
5 Jul 2016
President and CEO
Sold, plan not stated
112,000
$9.44M
9.6%
GILD Gilead Sciences
6 Jun 2016
President and CEO
Sold, plan not stated
112,000
$9.74M
9.6%
GILD Gilead Sciences
2 May 2016
President and CEO
Sold, plan not stated
112,000
$9.82M
9.6%
GILD Gilead Sciences
4 Apr 2016
President and CEO
Sold, plan not stated
112,000
$10.59M
9.6%
GILD Gilead Sciences
1 Mar 2016
President, COO and Director
Sold, plan not stated
112,000
$9.83M
9.6%
GILD Gilead Sciences
7 Dec 2015
President and COO
Sold, plan not stated
100,000
$10.32M
8.9%
GILD Gilead Sciences
9 Nov 2015
President and COO
Sold, plan not stated
100,000
$10.77M
8.9%
GILD Gilead Sciences
7 Oct 2015
President and COO
Sold, plan not stated
100,000
$9.92M
8.9%
GILD Gilead Sciences
8 Sep 2015
President and COO
Sold, plan not stated
100,000
$10.34M
8.9%
GILD Gilead Sciences
7 Aug 2015
President and COO
Sold, plan not stated
100,000
$11.39M
8.9%
GILD Gilead Sciences
7 Jul 2015
President and COO
Sold, plan not stated
100,000
$11.44M
8.9%
GILD Gilead Sciences
8 Jun 2015
President and COO
Sold, plan not stated
100,000
$11.41M
8.9%
GILD Gilead Sciences
7 May 2015
President and COO
Sold, plan not stated
100,000
$10.10M
8.9%
GILD Gilead Sciences
8 Dec 2014
President and COO
Sold, plan not stated
146,823
$15.60M
13.1%
GILD Gilead Sciences
7 Nov 2014
President and COO
Sold, plan not stated
146,895
$15.77M
13.1%
GILD Gilead Sciences
7 Oct 2014
President and COO
Sold, plan not stated
146,895
$15.37M
13.1%
GILD Gilead Sciences
8 Sep 2014
President and COO
Sold, plan not stated
146,895
$15.57M
13.1%
GILD Gilead Sciences
21 Nov 2013
President and COO
Sold, plan not stated
395,634
$28.32M
41.2%
GILD Gilead Sciences
14 Nov 2013
President and COO
Sold, plan not stated
395,635
$27.24M
41.2%
GILD Gilead Sciences
7 Nov 2013
President and COO
Sold, plan not stated
395,635
$26.71M
41.2%
GILD Gilead Sciences
2 Nov 2012
President and COO
Sold, plan not stated
70,000
$4.69M
20.6%
GILD Gilead Sciences
3 Oct 2012
President and COO
Sold, plan not stated
70,000
$4.89M
21.3%
GILD Gilead Sciences
4 Sep 2012
President and COO
Sold, plan not stated
140,000
$8.04M
35.1%
GILD Gilead Sciences
1 Dec 2009
President and COO
Sold, plan not stated
60,000
$2.76M
19.3%
GILD Gilead Sciences
1 Sep 2009
President and COO
Sold, plan not stated
60,000
$2.73M
19.3%
GILD Gilead Sciences
1 Jun 2009
President and COO
Sold, plan not stated
60,000
$2.57M
19.4%
GILD Gilead Sciences
7 May 2009
President and COO
Sold, plan not stated
87,300
$3.88M
25.9%
GILD Gilead Sciences
6 May 2009
President and COO
Sold, plan not stated
102,248
$4.51M
29.0%
GILD Gilead Sciences
5 May 2009
President and COO
Sold, plan not stated
199,092
$8.86M
44.3%
GILD Gilead Sciences
2 Mar 2009
President and COO
Sold, plan not stated
60,000
$2.67M
19.8%
GILD Gilead Sciences
1 Dec 2008
President and COO
Sold, plan not stated
60,000
$2.62M
21.3%
GILD Gilead Sciences
2 Sep 2008
President and COO
Sold, plan not stated
60,000
$3.10M
21.3%
GILD Gilead Sciences
2 Jun 2008
President and COO
Sold, plan not stated
60,000
$3.28M
21.3%
GILD Gilead Sciences
3 Mar 2008
COO and CFO
Sold, plan not stated
60,000
$2.88M
21.9%
GILD Gilead Sciences
3 Dec 2007
COO
Sold, plan not stated
60,000
$2.77M
22.4%
GILD Gilead Sciences
4 Sep 2007
COO and CFO
Sold, plan not stated
60,000
$2.20M
22.4%
GILD Gilead Sciences
4 Jun 2007
COO and CFO
Sold, plan not stated
30,000
$2.47M
22.5%
GILD Gilead Sciences
22 Feb 2007
EVP, Chief Financial Officer
Sold, plan not stated
20,000
$1.47M
16.2%
GILD Gilead Sciences
30 Oct 2006
EVP, Chief Financial Officer
Sold, plan not stated
30,000
$2.06M
23.2%
43 decisions on file.